Clinical comparative efficacy and safety of Polyherbal Unani formulations.
- Conditions
- Health Condition 1: J39- Other diseases of upper respiratory tract
- Registration Number
- CTRI/2023/03/050913
- Lead Sponsor
- State Unani Medical College, himmatganj Prayagraj
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
The following patients will be included
1 More than twelve weeks of persistent symptoms of rhinosinusitis
2 X ray PNS Waters view shows haziness or opacity and may show free fluid level in affected sinus
3 Those are signed on the consent paper and ready to follow protocol
4 Patient age within the range of 18 to 60 years
5 Both the gender Male & Female
The following patients will be excluded:
1 Patientâ??s age below 18 years and above 60 years
2 Pregnant and Lactating women
3 Nasal polyp, deviated nasal septum, mucocele, cyst, antrochoanal polyp,
facial trauma
4 Significant Pulmonary/ Cardiovascular/ Hepato-renal dysfunctions
5 Known cases of immunocompromised states (HIV, AIDS etc.)
6 Patients not willing to attend treatment schedule regularly
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the response to treatment will be assessed using the following parameters <br/ ><br> <br/ ><br>X-ray PNS <br/ ><br>CSAS (chronic sinusitis assessment score)Timepoint: Clinical assessment will be done at 0,1,2,3,4 weeks
- Secondary Outcome Measures
Name Time Method CSAS (chronic sinusitis assessment scoreTimepoint: 10th,20th dat